179 related articles for article (PubMed ID: 2311946)
1. Posterior vitreous detachment following panretinal laser photocoagulation.
Sebag J; Buzney SM; Belyea DA; Kado M; McMeel JW; Trempe CL
Graefes Arch Clin Exp Ophthalmol; 1990; 228(1):5-8. PubMed ID: 2311946
[TBL] [Abstract][Full Text] [Related]
2. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
3. Posterior vitreous detachment and neovascularization in diabetic retinopathy.
Akiba J; Arzabe CW; Trempe CL
Ophthalmology; 1990 Jul; 97(7):889-91. PubMed ID: 2381702
[TBL] [Abstract][Full Text] [Related]
4. The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.
Wade EC; Blankenship GW
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):226-31. PubMed ID: 2193849
[TBL] [Abstract][Full Text] [Related]
5. Role of the vitreous in diabetic retinopathy. I. Vitreous changes in diabetic retinopathy and in physiologic aging.
Tagawa H; McMeel JW; Furukawa H; Quiroz H; Murakami K; Takahashi M; Trempe CL
Ophthalmology; 1986 May; 93(5):596-601. PubMed ID: 3725319
[TBL] [Abstract][Full Text] [Related]
6. Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation.
Kleinmann G; Hauser D; Schechtman E; Landa G; Bukelman A; Pollack A
Int Ophthalmol; 2008 Feb; 28(1):29-34. PubMed ID: 17619829
[TBL] [Abstract][Full Text] [Related]
7. Role of the vitreous in diabetic retinopathy. II. Active and inactive vitreous changes.
Tagawa H; McMeel JW; Trempe CL
Ophthalmology; 1986 Sep; 93(9):1188-92. PubMed ID: 2433663
[TBL] [Abstract][Full Text] [Related]
8. Incremental panretinal photocoagulation. Results in treating proliferative diabetic retinopathy.
Rogell GD
Retina; 1983; 3(4):308-11. PubMed ID: 6201975
[TBL] [Abstract][Full Text] [Related]
9. Tractional Retinal Detachment in Eyes with Vitreous Hemorrhage and Proliferative Diabetic Retinopathy and Posterior Vitreous Detachment in Fellow Eye.
Joo CW; An Y; Kim YK; Kim YD; Park SP; Kim KL
Korean J Ophthalmol; 2023 Jun; 37(3):207-215. PubMed ID: 37068834
[TBL] [Abstract][Full Text] [Related]
10. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
12. A case of proliferative diabetic retinopathy in which scintillating particles appeared in the intravitreal cavity after laser photocoagulation.
Kohmoto R; Kobayashi T; Sato T; Kimura D; Fukumoto M; Tajiri K; Kida T; Ikeda T
BMC Ophthalmol; 2017 Dec; 17(1):254. PubMed ID: 29258460
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.
Lövestam-Adrian M; Agardh CD; Torffvit O; Agardh E
Acta Ophthalmol Scand; 2003 Jun; 81(3):221-5. PubMed ID: 12780397
[TBL] [Abstract][Full Text] [Related]
14. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy.
Liggett PE; Lean JS; Barlow WE; Ryan SJ
Am J Ophthalmol; 1987 Feb; 103(2):146-9. PubMed ID: 3812616
[TBL] [Abstract][Full Text] [Related]
16. Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy.
Doft BH; Blankenship G
Ophthalmology; 1984 Dec; 91(12):1453-7. PubMed ID: 6084215
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
18. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
19. "Early" vitrectomy for vasoproliferative retinopathy in patients with insulin-dependent diabetes mellitus.
Shea M; Young PW; Howcroft MJ
Can J Ophthalmol; 1982 Aug; 17(4):150-2. PubMed ID: 6181859
[TBL] [Abstract][Full Text] [Related]
20. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
